Eiger BioPharmaceuticals, Inc. (EIGRQ)
OTCMKTS: EIGRQ · Delayed Price · USD
13.50
+0.20 (1.50%)
Jul 26, 2024, 3:41 PM EDT - Market closed
Eiger BioPharmaceuticals Market Cap
Eiger BioPharmaceuticals has a market cap or net worth of $19.99 million as of July 26, 2024. Its market cap has decreased by -55.18% in one year.
Market Cap
19.99M
Enterprise Value
35.75M
1-Year Change
-55.18%
Ranking
n/a
Category
Stock Price
Market Cap Chart
Since January 30, 2014, Eiger BioPharmaceuticals's market cap has decreased from $140.60M to $19.99M, a decrease of -85.78%. That is a compound annual growth rate of -17.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2024 | 2.60M | -74.00% |
| Dec 29, 2023 | 10.00M | -80.77% |
| Dec 30, 2022 | 52.00M | -70.50% |
| Dec 31, 2021 | 176.30M | -55.90% |
| Dec 31, 2020 | 399.80M | 9.53% |
| Dec 31, 2019 | 365.00M | 88.14% |
| Dec 31, 2018 | 194.00M | 32.24% |
| Dec 29, 2017 | 146.70M | 50.62% |
| Dec 30, 2016 | 97.40M | 176.70% |
| Dec 31, 2015 | 35.20M | -92.27% |
| Dec 31, 2014 | 455.40M | 223.90% |
| Jan 30, 2014 | 140.60M | - |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly | 815.05B |
| Novo Nordisk | 577.86B |
| UnitedHealth Group | 513.32B |
| Johnson & Johnson | 373.76B |
| Merck & Co. | 317.56B |
| AbbVie | 309.20B |
| AstraZeneca | 245.50B |
| Thermo Fisher | 217.20B |